Protea Biosciences Group Inc (PRGBQ) financial statements (2022 and earlier)

Company profile

Business Address 1311 PINEVIEW DRIVE
MORGANTOWN, WV 26505
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7963231,08628
Cash and cash equivalents7963231,08628
Receivables437196393217128
Inventory, net of allowances, customer advances and progress billings92111161465905
Inventory92111161465905
Prepaid expense1219854305
Prepaid expense and other current assets30
Other undisclosed current assets   435309
Total current assets:7294129312,5091,399
Noncurrent Assets
Property, plant and equipment2,4662,6272,9602,8862,790
Deposits noncurrent assets  13723 
Other noncurrent assets19513723
Prepaid expense and other noncurrent assets23
Other undisclosed noncurrent assets  (137)(23) 
Total noncurrent assets:2,4852,6323,0972,9092,813
TOTAL ASSETS:3,2143,0444,0285,4184,212
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4942951,7061,069764
Accounts payable41331,253  
Accrued liabilities682831  
Employee-related liabilities120124220  
Taxes payable01   
Interest and dividends payable265109202  
Other undisclosed accounts payable and accrued liabilities   1,069764
Debt4,0121,3241,4581,0541,374
Due to related parties3,0882,5751,381  
Deferred revenue and credits588016  
Other undisclosed current liabilities7,8985,3183,2044,1027,894
Total current liabilities:15,5509,5907,7666,22510,033
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,7691,7261,8171,5802,083
Other undisclosed long-term debt and lease obligation1,7691,7261,8171,5802,083
Liabilities, other than long-term debt   624(23)
Customer advances or deposits    (23)
Derivative instruments and hedges, liabilities   624 
Total noncurrent liabilities:1,7691,7261,8172,2042,060
Total liabilities:17,32011,3169,5838,42912,093
Stockholders' equity
Stockholders' equity attributable to parent, including:(14,106)(8,273)(5,555)(3,011)(7,904)
Preferred stock  0  
Common stock1613773
Additional paid in capital81,12371,31264,30654,51737,993
Accumulated other comprehensive income (loss)00(0)23(6)
Accumulated deficit(95,246)(79,598)   
Other undisclosed stockholders' equity attributable to parent  (69,867)(57,558)(45,894)
Total stockholders' equity:(14,106)(8,273)(5,555)(3,011)(7,904)
Other undisclosed liabilities and equity    23
TOTAL LIABILITIES AND EQUITY:3,2143,0444,0285,4184,212

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
2,4472,0031,7681,223834
Cost of revenue(1,706)(722)(872)  
Gross profit:7411,2828961,223834
Operating expenses(6,234)(8,422)(11,671)(12,647)(10,815)
Other undisclosed operating income  811,0991,000
Operating loss:(5,493)(7,140)(10,693)(10,325)(8,980)
Nonoperating expense(10,155)(2,434)(782)(1,093)(551)
Investment income, nonoperating  1,246  
Interest and debt expense(1,968)(60)(745)(4)(30)
Loss from continuing operations before equity method investments, income taxes:(17,616)(9,635)(12,220)(11,422)(9,561)
Other undisclosed income from continuing operations before income taxes1,96860745430
Net loss available to common stockholders, diluted:(15,648)(9,574)(11,475)(11,418)(9,531)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(15,648)(9,574)(11,475)(11,418)(9,531)
Comprehensive loss:(15,648)(9,574)(11,475)(11,418)(9,531)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(23)30(21)
Comprehensive loss, net of tax, attributable to parent:(15,648)(9,574)(11,498)(11,388)(9,552)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: